Company led medicines recall: Noidecs T20/C4 (THC 20%; CBD <4%) Indica Cannabis Flower (unlicensed medicine) and Noidecs T20/C4 (THC 20%; CBD <4%) Sativa Cannabis Flower (unlicensed medicine)

The importer and distributor has informed MHRA of reports that two affected batches may be contaminated with mould, therefore these batches are being recalled as a precautionary measure.

Medicines and Healthcare products Regulatory Agency